Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 27, 2026 08:00 ET | Source: Callio Therapeutics

Callio Therapeutics to Present Phase 1 Trial Design of CLIO-8221, Novel Dual-Payload ADC, at ASCO 2026

Callio Therapeutics will present a trial-in-progress poster highlighting the CLIO-8221 Phase 1 trial design at the 2026 ASCO Annual Meeting in Chicago.
April 15, 2026 08:00 ET | Source: Callio Therapeutics

Callio Therapeutics to Present Poster on CLIO-8221, a Novel Dual-Payload Antibody-Drug Conjugate, at AACR 2026

At AACR 2026, Callio Therapeutics will present data that highlight the potential of CLIO-8221 as a therapeutic option for HER2-expressing cancers